Compass Therapeutics CMPX
NASDAQ CMPX
$0.90 -0.14 (-13.36%)
At close: Oct 1, 2026 · 4:00 PM EDT

Compass Therapeutics (CMPX) Other Accumulated Expenses (2019 - 2026)

Updated

Compass Therapeutics (CMPX) recorded Other Accumulated Expenses of $1.18 million in Q2 2026, up 208.1% from $384,000 a year earlier and up 67.1% from the prior quarter.

Analysis

Compass Therapeutics (CMPX) Other Accumulated Expenses (2019 - 2026) Analysis & Trends

At the end of FY2025, Compass Therapeutics reported Other Accumulated Expenses of $484,000, down 22.1% from FY2024.

  • Annual Other Accumulated Expenses has a five-year compound annual growth rate of 4.8% (FY2020 to FY2025).
  • Across earlier years, Other Accumulated Expenses came in at $621,000 in FY2024 (+158.8%), $240,000 in FY2023 (+150.0%), $96,000 in FY2022 (-79.6%) and $470,000 in FY2021 (+22.7%).
  • The Q2 2026 figure is the highest quarterly Other Accumulated Expenses since Q1 2022.
  • On a year-over-year basis, Other Accumulated Expenses rose in four of the last eight quarters, with growth averaging 56.6%.
  • Peak year-over-year performance for Other Accumulated Expenses in the last five years was growth of 344.3% in Q3 2023, against a decline of 90.6% in Q1 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at $708,000 (Q1 2026), $484,000 (Q4 2025) and $141,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Compass Therapeutics 187.29 Mn 187.29 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.18 Mn
Mar 31, 2026 708,000.00
Dec 31, 2025 484,000.00
Sep 30, 2025 141,000.00
Jun 30, 2025 384,000.00
Mar 31, 2025 274,000.00
Dec 31, 2024 621,000.00
Sep 30, 2024 167,000.00
Jun 30, 2024 308,000.00
Mar 31, 2024 281,000.00
Dec 31, 2023 240,000.00
Sep 30, 2023 391,000.00
Jun 30, 2023 255,000.00
Mar 31, 2023 137,000.00
Dec 31, 2022 96,000.00
Sep 30, 2022 88,000.00
Jun 30, 2022 292,000.00
Mar 31, 2022 1.47 Mn
Dec 31, 2021 470,000.00
Sep 30, 2021 734,000.00
API Access

Compass Therapeutics Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=CMPX&period=max&api_key=YOUR_API_KEY